1.
MMW Fortschr Med
; 166(11): 65, 2024 06.
Article
in German
| MEDLINE
| ID: mdl-38871918
2.
MMW Fortschr Med
; 166(11): 66, 2024 06.
Article
in German
| MEDLINE
| ID: mdl-38871921
3.
4.
MMW Fortschr Med
; 166(8): 66, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38693401
Subject(s)
Asthma , Pulmonary Disease, Chronic Obstructive , Humans , Pulmonary Disease, Chronic Obstructive/economics , Pulmonary Disease, Chronic Obstructive/therapy , Asthma/economics , Asthma/drug therapy , Germany , National Health Programs/economics , Anti-Asthmatic Agents/economics , Anti-Asthmatic Agents/therapeutic use , Drug Costs , Bronchodilator Agents/therapeutic use , Bronchodilator Agents/economics
5.
MMW Fortschr Med
; 166(8): 65, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38693398
6.
MMW Fortschr Med
; 166(10): 70, 2024 06.
Article
in German
| MEDLINE
| ID: mdl-38806935
7.
MMW Fortschr Med
; 166(9): 65, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38755389
8.
MMW Fortschr Med
; 166(6): 66, 2024 04.
Article
in German
| MEDLINE
| ID: mdl-38581524
9.
10.
11.
MMW Fortschr Med
; 166(7): 66, 2024 04.
Article
in German
| MEDLINE
| ID: mdl-38637402
12.
13.
14.
15.
16.
MMW Fortschr Med
; 166(5): 82, 2024 03.
Article
in German
| MEDLINE
| ID: mdl-38514576
17.
MMW Fortschr Med
; 166(4): 73, 2024 03.
Article
in German
| MEDLINE
| ID: mdl-38453875
18.
19.
20.
MMW Fortschr Med
; 166(2): 73, 2024 02.
Article
in German
| MEDLINE
| ID: mdl-38332302